Proteus Ends Deal with Otsuka, Refocuses on Oncology and Infectious Diseases Treatment

Proteus Otsuka end deal
Proteus has prematurely ended its high profile $88 million deal with Otsuka, reports MobiHealthNews. Proteus’ CEO, Andrew Thompson, told STAT News that the company and Otsuka Pharmaceutical have ended a deal in which Otsuka had been paying Proteus to help it develop a portfolio of digital medicines for serious mental health conditions. Read more This […]